LifeVantage Corp  

(Public, NASDAQ:LFVN)   Watch this stock  
Find more results for George Metzger�
1.35
+0.05 (3.85%)
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.28 - 1.36
52 week 1.10 - 1.80
Open 1.30
Vol / Avg. 477,454.00/279,578.00
Mkt cap 134.04M
P/E 11.22
Div/yield     -
EPS 0.12
Shares 99.29M
Beta 0.89
Inst. own 12%
Feb 2, 2015
Q2 2015 LifeVantage Corp Earnings Release (Estimated) Add to calendar
Nov 19, 2014
LifeVantage Corp Annual Shareholders Meeting
Nov 6, 2014
Q1 2015 LifeVantage Corp Earnings Call - Webcast
Nov 6, 2014
Q1 2015 LifeVantage Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 9.13% 5.32%
Operating margin 15.04% 9.09%
EBITD margin - 10.07%
Return on average assets 34.18% 20.79%
Return on average equity 338.21% 60.01%
Employees 201 -
CDP Score - -

Address

Suite 100, 9815 S. Monroe Street
SANDY, UT 84070
United States - Map
+1-801-4329000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lifevantage Corporation (Lifevantage) is engaged in the identification, research, development, manufacture and distribution of advanced nutraceutical dietary supplements, including its product, Protandim, the Nrf2 Synergizer and its anti-aging skin care product, LifeVantage TrueScience. The Company focuses its ongoing internal research efforts on oxidative stress solutions, particularly the activation of nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to health-related disorders. The Company provides products and network marketing business opportunity to customers and independent distributors. The Company sells its products in the United States, Japan, Australia and Mexico through a network of independent distributors, and to preferred and retail customers. In April 2014, the Company acquired a line of sports nutrition products known as Wicked Fast Sports Nutrition.

Officers and directors

Douglas C. Robinson President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
David S. Colbert Chief Financial Officer, Treasurer
Age: 45
Bio & Compensation  - Reuters
Robert M. Urban Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Ryan Thompson Senior Vice President - Global Sales
Age: 44
Bio & Compensation  - Reuters
Shawn Talbott Ph.D. Chief Science Officer
Age: 47
Bio & Compensation  - Reuters
Michelle Oborn-Virchow Vice President - Human Resources
Age: 34
Bio & Compensation  - Reuters
Robert H. Cutler General Counsel, Corporate Secretary
Age: 46
Bio & Compensation  - Reuters
David Phelps Global Chief Sales Officer
Age: 58
Bio & Compensation  - Reuters
Michael A. Beindorff Independent Director
Age: 62
Bio & Compensation  - Reuters
David S. Manovich Independent Director
Age: 62
Bio & Compensation  - Reuters